Richa Poddar - Feb 10, 2022 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role: Chief Commercial Officer
Signature: /s/ William Cook, as Attorney in Fact for Richa Poddar
Stock symbol: AGIO
Transactions as of: Feb 10, 2022
Transactions value $: -$22,783
Form type: 4
Date filed: 2/14/2022, 03:06 PM
Previous filing: Dec 15, 2021
Next filing: Feb 16, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGIO	Common stock	Options Exercise	$0	+2.07K	+1378.67%	$0.00	2.22K	Feb 10, 2022	Direct	F1
transaction	AGIO	Common stock	Tax liability	-$22.8K	-725	-32.69%	$31.43	1.49K	Feb 10, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGIO	Restricted stock units	Options Exercise	$0	-2.07K	-33.33%	$0.00	4.14K	Feb 10, 2022	Common stock	2.07K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F2	The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.